Q

Q-State Biosciences

38 employees

Q-State has developed world-leading technologies and proprietary approaches for probing rare and genetic CNS conditions.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Pharmaceutical

Life Science

Neurology

Transcriptomics

Drug Discovery

Gene Editing

Optogenetics

Genetic Therapies

Health Care

Therapeutic Design & Screening

Personalized Medicine

Precision Medicine

Neurodegenerative

Cardiology

Stem Cells

Functional Genomics

Human Models

Optical Electrophysiology

Rare Disease

Machine Learning

Genomics

Disrupting Medicine

Date founded

2013

Funding rounds raised

Total raised

$1.3M

from 1 investors over 1 rounds

Q

Q-State Biosciences raised $1.3M on July 20, 2021

Investors: National Cancer Institute